MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/cia.s600031

Медицинская библиотека · Clinical interventions in aging · 2026

Long-Term Surgical Outcomes and Influential Factors of Subthalamic Nucleus Deep Brain Stimulation for Dyskinesia in Parkinson's Disease: A 3-Year Longitudinal Cohort Study.

Wang Shu, Xue Tao, Ma Ruoyu, Shi Lin, Zhu Guanyu, Jiang Yin, Yang Anchao, Meng Fangang, Zhang Jianguo

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Subthalamic deep brain stimulation (STN-DBS) has emerged for Parkinson's disease (PD), but its long-term effects on levodopa-induced dyskinesia (LID) remain poorly understood.

OBJECTIVE

To assess the long-term LID outcomes and prognostic factors of STN-DBS.

METHODS

A single-blind longitudinal cohort study was conducted in evaluating 84 PD patients with LID (mean age 61.89 years; 46.4% female; mean disease duration 10.30 years; and mean baseline levodopa-equivalent dose 854.16 mg/day) who underwent STN-DBS at Beijing Tiantan Hospital, Capital Medical University between 2019 and 2021. Assessments at baseline, 1-year (short-term), and 3-year (long-term) regarding motor symptoms, quality of life, neuropsychological status, and cognitive function were analyzed. Primary outcomes focused on LID symptoms (Unified Dyskinesia Rating Scale [UDysRS]). Multivariable linear regression identified prognostic factors.

RESULTS

At 1-year, the UDysRS score improved significantly (74.4% reduction, P<0.001), with sustained but diminished benefits at 3-year (64.9% reduction vs baseline, P<0.001; 36.9% decline vs 1 year, P=0.012). The time and functional impact of LID also improved initially (62.5% and 64.3% reduction) but worsened over time (38.8% and 33.3% decline). Motor function and quality of life showed similar trends, while neuropsychological symptoms improved stably even after long-term follow-up; and cognitive function remained unchanged. Multivariable regression identified diphasic dyskinesia as a negative prognostic factor (short-term std.β=-0.296; long-term std.β=-0.239), whereas a higher levodopa-equivalent dose (short-term std.β=0.275; long-term std.β=0.261) and greater levodopa responsiveness (short-term std.β=0.215; long-term std.β=0.216) predicted better short- and long-term results. A longer disease duration correlated with worse long-term outcomes (std.β=-0.212).

CONCLUSION

STN-DBS was associated with significant long-term improvements in LID, although the effectiveness gradually declined. The identified prognostic factors help in patient selection and counseling.

Для цитирования: Wang Shu, Xue Tao, Ma Ruoyu, Shi Lin, Zhu Guanyu, Jiang Yin, Yang Anchao, Meng Fangang, Zhang Jianguo. Long-Term Surgical Outcomes and Influential Factors of Subthalamic Nucleus Deep Brain Stimulation for Dyskinesia in Parkinson's Disease: A 3-Year Longitudinal Cohort Study.. Clinical interventions in aging. 2026. DOI: 10.2147/cia.s600031.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.